Nicolai Stransky

7PUBLICATIONS
33CO-AUTHORS
Molecular targetsScience, technology and engineering curriculum and pedagogyCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersWastewater treatment processes
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Nov 23, 2023
Efficacy of combined tumor irradiation and KCa3.1-targeting with TRAM-34 in a syngeneic glioma mouse model.

Nicolai Stransky, Katrin Ganser, Leticia Quintanilla-Martinez

|Jan 05, 2023
Ten simple rules for implementing open and reproducible research practices after attending a training course.

Verena Heise, Constance Holman, Hung Lo

|Dec 23, 2022
Tumoricidal, Temozolomide- and Radiation-Sensitizing Effects of KCa3.1 K+ Channel Targeting In Vitro Are Dependent on Glioma Cell Line and Stem Cell Fraction.

Nicolai Stransky, Katrin Ganser, Ulrike Naumann

|Apr 23, 2022
Comment on Chen et al. Dual Blockade of Lactate/GPR81 and PD-1/PD-L1 Pathways Enhances the Anti-Tumor Effects of Metformin. Biomolecules 2021, 11, 1373.

Nicolai Stransky, Stephan M Huber

|Jan 27, 2022
Patient-individual phenotypes of glioblastoma stem cells are conserved in culture and associate with radioresistance, brain infiltration and patient prognosis.

Katrin Ganser, Franziska Eckert, Andreas Riedel

|Dec 24, 2021
Can Any Drug Be Repurposed for Cancer Treatment? A Systematic Assessment of the Scientific Literature.

Nicolai Stransky, Peter Ruth, Matthias Schwab

Pageof 2

Frequent Collaborators

2 joint publications

Franziska Eckert

2 joint publications

Stephan M Huber

1 joint publications

Markus W Löffler

1 joint publications

Ulrike Naumann